TW266155B - - Google Patents

Info

Publication number
TW266155B
TW266155B TW081105312A TW81105312A TW266155B TW 266155 B TW266155 B TW 266155B TW 081105312 A TW081105312 A TW 081105312A TW 81105312 A TW81105312 A TW 81105312A TW 266155 B TW266155 B TW 266155B
Authority
TW
Taiwan
Application number
TW081105312A
Other languages
Chinese (zh)
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of TW266155B publication Critical patent/TW266155B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW081105312A 1991-07-05 1992-07-04 TW266155B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL98747A IL98747A0 (en) 1991-07-05 1991-07-05 Ophthalmic compositions

Publications (1)

Publication Number Publication Date
TW266155B true TW266155B (en:Method) 1995-12-21

Family

ID=11062614

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081105312A TW266155B (en:Method) 1991-07-05 1992-07-04

Country Status (9)

Country Link
EP (1) EP0521799A1 (en:Method)
JP (1) JPH05186333A (en:Method)
KR (1) KR930001929A (en:Method)
AU (1) AU650351B2 (en:Method)
CA (1) CA2073141A1 (en:Method)
IE (1) IE922139A1 (en:Method)
IL (1) IL98747A0 (en:Method)
TW (1) TW266155B (en:Method)
ZA (1) ZA924974B (en:Method)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
SG49746A1 (en) * 1992-08-28 1998-06-15 Pharmos Corp Submicron emulsions as ocular drug delivery vehicles
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
DE19511322C2 (de) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
DE19527132A1 (de) * 1995-07-25 1997-01-30 Laevosan Gmbh & Co Kg Ophthalmologische Ozonschutzzusammensetzung
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
EP0760237A1 (en) * 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
GB9524452D0 (en) * 1995-11-30 1996-01-31 Award Plc Contact lens packaging
AU5342498A (en) * 1997-01-10 1998-08-03 Wakamoto Pharmaceutical Co., Ltd. Difluprednate-containing ophthalmic o/w emulsion composition
US6015574A (en) * 1997-06-09 2000-01-18 L'oreal Lipophilic carrier systems
WO1999016471A1 (fr) 1997-10-01 1999-04-08 Wakamoto Pharmaceutical Co., Ltd. Compositions d'emulsions de type aqueux
US20010009672A1 (en) 1998-12-04 2001-07-26 L'oreal Compositions and methods for controlling deposition of water-insoluble
US20010006654A1 (en) 1998-12-09 2001-07-05 L'oreal Compositions and methods for treating hair and skin using aqueous delivery systems
US6440456B1 (en) 1999-06-09 2002-08-27 L'oreal S.A. Aqueous carrier systems for lipophilic ingredients
DE10030378A1 (de) * 2000-06-21 2002-03-14 Audit Inst For Medical Service Neue pharmazeutische Zusammensetzung zur topischen Anwendung von wasserunlöslichen und/oder schwer wasserlöslichen Wirkstoffen
KR101188156B1 (ko) * 2003-09-10 2012-10-05 센주 세이야꾸 가부시키가이샤 콘택트렌즈용 안과용 조성물
EP1611879B1 (en) * 2004-07-02 2009-08-12 Novagali Pharma SA Use of emulsions for intra- and periocular injection
EP1985298A1 (en) 2007-04-24 2008-10-29 Azad Pharma AG Ophtalmic oil-in-water emulsions containing prostaglandins
FR2916636B1 (fr) * 2007-05-29 2009-09-04 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
DE102010023949A1 (de) * 2010-06-16 2011-12-22 F. Holzer Gmbh In-situ Lecithin-Mikroemulsionsgel-Formulierung
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
CA3072768C (en) * 2017-08-27 2024-06-11 Rhodes Technologies Pharmaceutical compositions for the treatment of ophthalmic conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2528516A1 (de) * 1974-07-05 1976-01-22 Sandoz Ag Neue galenische zubereitung
US4146499A (en) * 1976-09-18 1979-03-27 Rosano Henri L Method for preparing microemulsions
DE3020129A1 (de) * 1980-05-27 1981-12-03 Dr. Thilo & Co GmbH, 8021 Sauerlach Arzneimittelzubereitung zur anwendung am auge
JPS62270521A (ja) * 1986-05-16 1987-11-24 Green Cross Corp:The フルルビプロフエン眼投与製剤
CA2013755C (en) * 1989-04-05 1993-11-30 Simon Benita Medicinal emulsions

Also Published As

Publication number Publication date
AU650351B2 (en) 1994-06-16
CA2073141A1 (en) 1993-01-06
AU1940292A (en) 1993-03-11
JPH05186333A (ja) 1993-07-27
IL98747A0 (en) 1992-07-15
ZA924974B (en) 1993-03-31
KR930001929A (ko) 1993-02-22
EP0521799A1 (en) 1993-01-07
IE922139A1 (en) 1993-01-13

Similar Documents

Publication Publication Date Title
CH0502314H1 (en:Method)
EP0536964A3 (en:Method)
EP0545711A3 (en:Method)
TW266155B (en:Method)
ATA37391A (en:Method)
AU8357291A (en:Method)
JPH0497355U (en:Method)
JPH0498745U (en:Method)
EP0527395A3 (en:Method)
AU8831091A (en:Method)
AU7627691A (en:Method)
AU7633391A (en:Method)
AU7714891A (en:Method)
AU7824891A (en:Method)
EP0766382A3 (en:Method)
EP0584208A4 (en:Method)
AU7841391A (en:Method)
EP0561000A4 (en:Method)
AU8024591A (en:Method)
EP0548681A3 (en:Method)
EP0548533A3 (en:Method)
EP0545684A3 (en:Method)
EP0542313A3 (en:Method)
EP0529334A3 (en:Method)
AU7190991A (en:Method)